type here...

CATEGORIES

Healthcare

LATEST

1...464748...76Page 47 of 76

TRENDING

EDITORS CHOICE

First NASH Patient Dosed with CRV431 in Phase 2 ‘AMBITION’ Clinical Trial

Medika Life -
The ‘AMBITION' trial, is designed to assess safety, tolerability, and pharmacokinetics of 75 mg CRV431, administered orally to F2 and F3 NASH patients

Implementing AI – Artificial, Augmented, or Amplified – is Complex and Unavoidable

Gil Bashe, Medika Life Editor -
The health ecosystem is complex and fragmented - embracing AI may be what medicine needs to transform.

New Alzheimer’s Drugs Will Worsen Inequality

Julian Willett, MD -
Disclosure: I own a fraction of a share of Eli Lilly stock. We live in a very exciting time! Alzheimer’s medications that are more promising...

Home Cooking Means Hidden Health Dangers for You

Pat Farrell PhD -
Economic change brings on lifestyle change, and with less money available to buy prepared foods, millions are now cooking at home. One of the...

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories